Skip to content
hcg-service-hero-1

Insights From Halloran

Elizabeth BodiApr 14, 2025 5:52:43 PM1 min read

Key Update on Guideline for Good Clinical Practice E6(R3)

January 6, 2025: ICH assembly agreed that ICH GCP E6 R3 Principles and Annex 1 could be ...
Start Reading
Mike Fusakio PhDApr 14, 2025 4:38:00 PM2 min read

Impact on Product Development: FDA Phasing Out Animal Testing Requirement

Contributing Author: Hema Balasubramanian The FDA announcement on its plan to phase out ...
Start Reading
Carolina Ahrendt, MBA, PMPApr 10, 2025 12:40:26 PM6 min read

Ticking Timeline: Tips for Effective Product Development Timelines

Once a biotech or pharmaceutical company defines their product development objectives ...
Start Reading
Sheila GwizdakApr 7, 2025 9:34:32 AM1 min read

Impacts of ICH GCP E6 (R3) Webinar

Join Halloran Consulting Group for a compelling discussion on how to future-proof your ...
Start Reading
Kanchana IyerApr 3, 2025 10:30:00 AM3 min read

Navigating Drug, Biologic and Medical Device Regulatory Strategies

Contributing Author: Mamta Puri-Lechner In a recent webinar, Kanchana Iyer and Mamta ...
Start Reading
Daniel SmithMar 12, 2025 10:21:13 AM1 min read

FDA Announces Key Transition Dates for ESG NexGen

Halloran participated in the User Acceptance Testing last summer/fall and is excited ...
Start Reading
Pamela VizankoMar 4, 2025 4:00:00 PM3 min read

Pathway to Success: How De-Risking Life Sciences Companies Leads to Investment Growth

Biocom California hosted the Global Life Science Partnering and Investor Conference in ...
Start Reading
Meghan Patterson, MPHFeb 26, 2025 9:30:00 AM3 min read

Empowering Success in Small Pharma and Biotech for Optimal Results

Optimize budgets and teams to achieve efficiencies without compromising quality in small ...
Start Reading
Halloran Consulting GroupFeb 3, 2025 3:31:27 PM3 min read

Preparing Your Life Sciences Company for 2025

The 43rd Annual Healthcare Conference took place, January 13-16, 2025, in San Francisco, ...
Start Reading
Nicole GalloJan 13, 2025 11:19:45 AM4 min read

Early FDA Engagement is Essential

Navigating the FDA review process for investigational new drugs (INDs) is the critical ...
Start Reading